Data Set APSR 2.0 - Concept Diagnostic conclusionID: 2.16.840.1.113883.2.6.60.6.1.1Version Label: Live VersionConcepts: 38 (Groups: 6 - Items: 32) |
Click on triangles in the first column to open/close groups. Click the [-] sign to hide a column. Choose a column with 'Show column' to show it again. You can drag columns to re-arrange the view.
Name | ID[‑] | Datatype[‑] | Property[‑] | Example[‑] | Codes[‑] | Description[‑] | Source[‑] | Rationale[‑] | Operationalizations[‑] | Comment[‑] | Status[‑] | Terminology[‑] | Value Set[‑] | Type[‑] | Parent concept[‑] | Inherit from[‑] |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Diagnostic conclusion | psr-dataelement-45 | Diagnoses on all specimens that are delivered to the pathology department from one operation or patient visit from a single clinician (ordering provider) on a particular day. This is a critical summary of findings, giving an answer to the clinical question. The diagnoses for each specimen or group of specimens should be reported separately from each other. Additional pathologic finding(s) and the results of ancillary study(ies), diagrams and still images or virtual slides, if taken, may be included. In case of cancer, the tumor formula should be and any cancer checklist may be included. | IHE_PAT_Suppl_APSR_Rev2 0_TI_2015_20_05 |
|
draft |
|
Group | |||||||||
diagnostic conclusion text | psr-dataelement-108 | Text | Text of the diagnostic conclusion |
|
draft |
|
Item | Diagnostic conclusion | ||||||||
Generic AP observation | psr-dataelement-65 | Code | Atomic unit of a Generic AP observation, coded or as measurement value. Each generic observation must have a textual part for human readibility. |
|
draft |
|
AP Observation 2015-11-22T12:20:34 (dynamic / Extensible/CWE)
|
Item | Diagnostic conclusion | |||||||
Embedded Image | psr-dataelement-71 | Image of a specimen, or a schematic drawing, or part of a specimen, or a tissue section, embedded in an observation |
|
draft |
|
Group | Diagnostic conclusion | |||||||||
Image ID | psr-dataelement-69 | Identifier | Identifier of the image, issued by the LIS (Order filler or Image manager) as Image ID. |
|
draft |
|
Item | Embedded Image | ||||||||
Drawing | psr-dataelement-91 | Binary | Schematic drawing of a specimen processing, e.g. grossing |
|
draft |
|
Item | Embedded Image | ||||||||
Macroscopic image | psr-dataelement-92 | Binary | Image obtained by a macro-camera from specimen or part of a specimen |
|
draft |
|
Item | Embedded Image | ||||||||
Microscopic Image | psr-dataelement-37 | Binary | Microscopic image (e.g. WSI) of a slide or part of a slide |
|
draft |
|
Item | Embedded Image | ||||||||
ROI | psr-dataelement-93 | Binary | Region of interest in an image |
|
draft |
|
Item | Embedded Image | ||||||||
Scoring systems | psr-dataelement-57 | Code | Systems for semiquantitative assessment of grading, (immunohistochemical) staining results, and other observable entities. |
|
draft |
Assessment scales (assessment scale) (SNOMED Clinical Terms: 273249006)
Total Gleason score (observable entity) (SNOMED Clinical Terms: 384997002)
Nottingham Combined Grade (qualifier value) (SNOMED Clinical Terms: 372276001)
|
Item | Diagnostic conclusion | ||||||||
Tumor classification (ICD-O-3) | psr-dataelement-54 | System for the classification of tumors according their site (location) and their histology (morphology). Hosted by WHO (IARC) in the ICD-O (International classification of diseases (oncology) | http://www.who.int/classifications/icd/adaptations/oncology/en/ | Classification structureA multi-axial classification of the site, morphology, behaviour, and grading of neoplasms.The topography axis uses the ICD-10 classification of malignant neoplasms (except those categories which relate to secondary neoplasms and to specified morphological types of tumours) for all types of tumours, thereby providing greater site detail for non-malignant tumours than is provided in ICD-10. In contrast to ICD-10, the ICD-O includes topography for sites of haematopoietic and reticuloendothelial tumours.The morphology axis provides five-digit codes ranging from 8000/0 to 9989/3. The first four digits indicate the specific histological term. The fifth digit after the slash (/) is the behaviour code, which indicates whether a tumour is malignant, benign, in situ, or uncertain (whether benign or malignant). A separate one-digit code is also provided for histologic grading (differentiation) or cell type in lymphomas and leukemias.A complete code consists of 10 digits (4 for topography, 6 for morphology, behavior and grading), separated by a "." after the 3rd digit in topography and a "/" after the 4th digit in morphology (8th digit in total). Qualifier for laterality (1 additional digit) may be given after the topography code. |
|
draft |
Histology and Behavior ICD-O-3 Cancer (Logical Observation Identifier Names and Codes: 59847-4)
ICD-O-3 (International Classification of Diseases for Oncology: ICD-O: 2.16.840.1.113883.6.43.1)
|
Group | Diagnostic conclusion | |||||||
Topography (Tumor site) | psr-dataelement-73 | Code | Indicates the tumor site. The topography axis of ICD-O-3 uses the ICD-10 classification of malignant neoplasms (except those categories which relate to secondary neoplasms and to specified morphological types of tumours) for all types of tumours, thereby providing greater site detail for non-malignant tumours than is provided in ICD-10. In contrast to ICD-10, the ICD-O includes topography for sites of haematopoietic and reticuloendothelial tumours. | http://www.who.int/classifications/icd/adaptations/oncology/en/ |
|
draft |
Site coding system.current Cancer site (Logical Observation Identifier Names and Codes: 42129-7)
|
ICD-O-3 Topography 2015-11-13T19:16:23 (dynamic)
|
Item | Tumor classification (ICD-O-3) | ||||||
Morphology (Typing) | psr-dataelement-56 | Code | Classification of tumors according their morphology, resulting in tumor type. Classification System, part of ICD-O, hosted by WHO, published in the famous "blue books". Coded by the first 4 digits in the M chapter (Morphology axis) of ICD-O-3 (M-8000/0 to M-9989/3) |
http://www.who.int/classifications/icd/adaptations/oncology/en/ | Tumors are classified according their morphological properties, assuming that the morphology is an indicator for the original tissue component the tumor stems from. |
|
draft |
Histology ICD-O-3 Cancer (Logical Observation Identifier Names and Codes: 31205-8)
|
ICD-O-3 Morphology 2015-11-13T14:08:46 (dynamic)
|
Item | Tumor classification (ICD-O-3) | |||||
Behavior | psr-dataelement-72 | Code |
|
Indicates whether a tumour is malignant, benign, in situ, or uncertain (whether benign or malignant). Coded by the first digit after the slash in the M chapter (Morphology axis) of ICD-O-3 |
http://www.who.int/classifications/icd/adaptations/oncology/en/ |
|
draft |
Behavior ICD-O-3 Cancer (Logical Observation Identifier Names and Codes: 31206-6)
|
ICD-O-3 Behavior 2015-11-13T18:54:30 (dynamic)
|
Item | Tumor classification (ICD-O-3) | |||||
Differentiation | psr-dataelement-55 | Differentiation means Grading as classification of tumors according their assumed grade of malignancy. The most often three-tiered grading system is used. Furthermore, the cell type of lympoproliferative neoplasias is classified in that system, too. Both are coded by the second digit after the slash in the M chapter (Morphology axis) of ICD-O-3 It also means differentiation according the lymphocyte type in malignant lymphomas. |
http://www.who.int/classifications/icd/adaptations/oncology/en/ | All grading systems share the assumption that a tumor is as more malignant as it differs morphologically from the original tissue. Highly differentiated tumors (very similar to the original tissue) are low malignant (low grade, grade 1), poorly differentiated tumors are highly malignant ones (high grade, grade 3 or 4). |
|
draft |
Histological grade finding (finding) (SNOMED Clinical Terms: 373372005)
|
Group | Tumor classification (ICD-O-3) | |||||||
Grading/Immunophenotype | psr-dataelement-104 | Code |
|
Differentiation of a malignant tumor, both as grading in a 4-tiered grading system (WHO-grading) and as immunophenotype for malignant lymphomas and some leukemias | http://www.who.int/classifications/icd/adaptations/oncology/en/ |
|
draft |
Grade Cancer (Logical Observation Identifier Names and Codes: 21858-6)
|
ICD-O-3 Differentiation 2015-11-13T19:07:32 (dynamic)
|
Item | Differentiation | |||||
Assessment Scales (Score) | psr-dataelement-99 | Code |
|
Assessment scales or scores are a special, highly structured form of clinical findings (see scoring systems) |
|
draft |
Assessment scales (assessment scale) (SNOMED Clinical Terms: 273249006)
|
Item | Differentiation | |||||||
Tumor formula (TNM) | psr-dataelement-3 | Tumor formula including T-, M- and N-values as well as further details (staging) and grading, well known as TNM classification, hosted by UICC | Sobin LH, Gospodarowicz MK, Wittekind Ch: TNM classification of malignant tumors.7th ed. 2010, 4th corrected postprint, Wiley&Sons |
|
draft |
Pathologic TNM stage grouping (observable entity) (SNOMED Clinical Terms: 399588009)
Clinical TNM stage grouping (observable entity) (SNOMED Clinical Terms: 399537006)
|
Group | Diagnostic conclusion | ||||||||
Stage | psr-dataelement-74 | Code | IVB |
|
Stage system (hosted by UICC) of a tumor disease, compiling the elements of TNM classification |
|
draft |
Stage group.pathology Cancer (Logical Observation Identifier Names and Codes: 21902-2)
|
UICC Stage (7ed) 2015-06-23T16:43:02 (dynamic)
|
Item | Tumor formula (TNM) | |||||
Posttherapeutic | psr-dataelement-29 | Code |
|
Symbol for TNM: Is this Observation performed after a multimodal therapy? |
|
draft |
y - During therapy/following treatment (tumor staging) (SNOMED Clinical Terms: 277649004)
|
Item | Tumor formula (TNM) | |||||||
Autopsy | psr-dataelement-28 | Code |
|
Symbol for TNM: Has this tumor formula been derived first at autopsy? |
|
draft |
a - At autopsy (tumor staging) (SNOMED Clinical Terms: 277646006)
|
Item | Tumor formula (TNM) | |||||||
Postoperative | psr-dataelement-59 | Boolean |
|
Qualifier (prefix) for T, N, and M category: Is this Observation performed after operative therapy, i.e. information comes from the pathologist |
|
draft |
p-pathological (1.2.276.0.76.3.1.131.1.5.1: tnmCp)
|
Item | Tumor formula (TNM) | |||||||
Clinical | psr-dataelement-60 | Code |
|
|
Qualifier (prefix) for T, N, and M category: Is this Observation performed by clinical methods? |
|
draft |
c-clinical (1.2.276.0.76.3.1.131.1.5.1: tnmCp)
|
TNM_Praefix_CP_UICC 2015-11-04T15:52:34 (dynamic)
|
Item | Tumor formula (TNM) | |||||
Multiplicity | psr-dataelement-61 | Code | pT2(m); pT2(3) |
|
Qualifier for pT category: Are there multiple tumors in the specimen removed or how many multiple tumors are in the specimen? |
|
draft |
m-multiple tumors (1.2.276.0.76.3.1.131.1.5.1: tnmMultiplicity)
|
UICC Multiplicity 2015-11-06T10:44:54 (dynamic)
|
Item | Tumor formula (TNM) | |||||
Recurrence | psr-dataelement-26 | Code |
|
Symbol for TNM: Is this tumor recurring from a previous disease.. |
|
draft |
r - Tumor recurrence (tumor staging) (SNOMED Clinical Terms: 277647002)
r (TNM Edition7 UICC: r)
r (TNM Edition6 UICC: r)
r (TNM Edition5 UICC: r)
|
Item | Tumor formula (TNM) | |||||||
Observation Timestamp | psr-dataelement-13 | Date/time |
|
point in time when this observation was made |
|
draft |
|
Item | Tumor formula (TNM) | |||||||
Nodes Affected | psr-dataelement-12 | Quantity | How many nodes are affected by tumor? |
|
draft |
|
Item | Tumor formula (TNM) | ||||||||
Nodes Examined | psr-dataelement-11 | Quantity | number of nodes examined |
|
draft |
|
Item | Tumor formula (TNM) | ||||||||
Sentinel Lymph Nodes | psr-dataelement-102 | Code | Regional lymph nodes according the sentinel concept: first draining lymph node for a tumor site |
|
draft |
Specimen from sentinel lymph node (specimen) (SNOMED Clinical Terms: 441709004)
|
Item | Tumor formula (TNM) | ||||||||
Isolated tumor cells (ITC) | psr-dataelement-103 | Code |
|
Single tumor cells or small cluster of tumor cells, not larger than 0.2 mm in diameter, usually detected by immunohistochemistry or molecular pathology. No typical characteristics of metastases (stromal reaction, proliferation). If such ITC are detected in lymph nodes, those are classified as pN0(i+) or pN0(mol+) (regional) or as pM0(i+) or pM0(mol+) (non-regional). For negativity of immunohistochemical or molecular pathologic findings in lymph nodes the same rules are applied (i- or mol-) |
|
draft |
|
UICC Isolated Tumor Cells 2017-03-13T09:48:35 (dynamic)
|
Item | Tumor formula (TNM) | ||||||
Micrometasis | psr-dataelement-106 | Code |
|
Micrometasis (equal or less than 0.2 mm in largest diameter) in regional or extra-regional lymph nodes (pN1 or pM1). Used as suffix for N- and M-category in TNM |
|
draft |
|
Item | Tumor formula (TNM) | |||||||
N-category | psr-dataelement-8 | Code |
|
N-category (regional lymph nodes) of the TNM classification |
|
draft |
Regional lymph nodes.pathology [Class] Cancer (Logical Observation Identifier Names and Codes: 21900-6)
|
UICC N category 2017-07-21T10:00:53 (dynamic)
|
Item | Tumor formula (TNM) | ||||||
M-category | psr-dataelement-7 | Code | M0, i.e. no distant metastases |
|
M-category (distant metastases) of the TNM classification |
|
draft |
Distant metastases.pathology [Class] Cancer (Logical Observation Identifier Names and Codes: 21901-4)
|
UICC M category 2017-07-21T10:31:38 (dynamic)
|
Item | Tumor formula (TNM) | |||||
T-category | psr-dataelement-6 | Code |
|
T-category of the TNM classification |
|
draft |
Primary tumor.pathology Cancer (Logical Observation Identifier Names and Codes: 21899-0)
|
UICC T category 2017-07-07T15:06:39 (dynamic)
|
Item | Tumor formula (TNM) | ||||||
Residual tumor status | psr-dataelement-46 | Code |
|
Status of residual tumor after any therapy |
|
draft |
Status of residual neoplasm (observable entity) (SNOMED Clinical Terms: 445200009)
|
UICC Residual tumor (R) classification 2015-06-25T11:23:51 (dynamic)
|
Item | Tumor formula (TNM) | ||||||
Grading | psr-dataelement-53 | Code |
|
Method of histopathology to describe semiquantitatively resp. to classify the grade of differentiation / grade of malignancy of a malignant tumor. It results in four-tiered, three-tiered or two-tiered tumor grades. There is a tendency to reduce all systems to a two-tiered grading of low and high grade. | Large deviations from normal histoarchitecture, high pleomorphism of cells, and high proliferative activity correspond with a highly malignant behaviour. Low structural abnormalities, low pleomorphism and a low proliferative activity correspond with a rather good prognosis. This holds true for the vast majority of malignant tumors. |
|
draft |
Histological grade finding (finding) (SNOMED Clinical Terms: 373372005)
|
UICC Grade 4 tiered 2015-11-13T19:46:53 (dynamic)
|
Item | Tumor formula (TNM) |